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Introduction and purpose
The successful treatment of Peripheral Arterial Occlusive
Disease (PAOD) relies on the restoration of a sufficient
blood supply to the ischemic tissue. Amongst many exper-
imental therapies, cell-based therapy offers an option to
enhance effective revascularization.
Magnetic Resonance Imaging (MRI) can be used to mon-
itor the cell delivery, as well as, to serially interrogate the
degree of cellular retention and engraftment but it lacks
the spatial resolution to detect neovascularization. How-
ever, MR contrast-enhanced, first-pass perfusion can offer
a non-invasive method to determine the functional conse-
quences of this process.
The purpose of the study was to determine the efficacy of
allogeneic mesenchymal stem cell (MSC) therapy in a
blinded, placebo controlled trial in a rabbit PAOD model
using non-invasive MRI.
Materials and methods
Mesenchymal stem cells were isolated from the bone mar-
row of male New Zealand White rabbits, expanded (3 pas-
sages), and magnetoelectroporated (MEP) with
ferumoxides for magnetic labeling[1].
Hindlimb ischemia was induced by a minimally invasive,
non-surgical, endovascular method where thrombogenic
platinum coils were deployed in the superficial femoral
artery[2]. Twenty-four hours after ischemia induction,
female rabbits were blinded to receive 13 × 106 MEP-
labeled MSCs (n = 6) or sham injections (0.3 mg/ml of Fe
in PBS) divided in six injections in the ischemic medial
thigh.
First pass, saturation recovery perfusion MRIs (3 T Philips
Achieva) were obtained after a Gadomer injection (0.01
mmol/kg IV, Schering AG) prior to, 7, and 14 days post-
cell injection. Signal-intensity time curves from MRI in the
right and left calf were evaluated and compared to X-ray
angiography (on day 15) and followed by postmortem
histological analysis. A cross-section time series linear
regression analysis with a P value < 0.05 was considered
statistically significant. Modified TIMI frame count, i.e.
comparing the difference in time of filling of the popliteal
bifurcation between the right non-ischemic and left
ischemic limb on X-ray angiography was used to assess
angiogenesis.
Histological analysis was performed on the medial thigh
to determine the induction of neovascularization based
on CD31 staining for endothelium and also to establish
MSCs fate and vessel size. The CD31 positive capillaries
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were manually counted in 6 comparable areas of right and
left hindlimbs and Poisson and Kruskal Wallis tests were
used for the data analysis.
Results
At baseline, the difference in MR perfusion upslope time
between ischemic (I) and non-ischemic (NI) limbs was
worse in MSC-treated rabbits (5.0 ± 3 s) vs. controls (3.7
± 3 s). At 2 weeks, TIMI frame counts showed similar ther-
apeutic effect in MSC and sham groups (7.7 ± 3 vs. 7.3 ±
3 s, P = NS). However, MRI perfusion in MSC rabbits
showed more improvement (difference decreased 2.1 ± 1
s, P < 0.04 vs. baseline) than controls (1.0 ± 1 s improve-
ment, P = NS), which mirrored histological analysis
results.
Increased capillary density in the left limb relative to the
right limb based on histological analysis (28 ± 20 MSC vs.
19 ± 22 control difference I vs. N, P = NS) was present in
all animals except one control animal.
Furthermore, histological analysis confirms incorporation
of the MSCs into the vessel walls.
Conclusion
In this preclinical model, MSC therapy show modest
improvements in MRI perfusion relative to controls. MRI
offers a non-invasive means to serially determine tissue
perfusion without arterial access that is concordant with
histological gold standards.
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